Since 2017, TRICARE has provided comprehensive obesity care for its beneficiaries — including coverage for FDA-approved obesity medications. But in August 2025, that changed. TRICARE announced that retirees would no longer have coverage for these medications and that other beneficiaries could only access coverage through in-network providers. This decision isn’t just unfair — it’s dangerous. It
Read Article